The LAMEA Defibrillators Market is expected to grow at a CAGR of 7.6% CAGR during 2016 - 2022. The Brazil market dominated the LAMEA Defibrillators Market in 2015 and would continue till 2022, growing at a CAGR of 7.0 % during the forecast period. The UAE market would witness the high growth rate of 10.1 % during 2016-2022. The Implantable Cardioverter Defibrillators (ICD) market dominated the LAMEA Defibrillators Market in 2015 and would grow at a CAGR of 8.7 % CAGR during 2016 - 2022. The Advanced Life Support (ALS) Defibrillators market is poised to attain a market value of $647.9 Million by 2022. The report highlights the adoption of Defibrillators in LAMEA region. Based on the product type; the Defibrillators market is segmented into Advanced Life Support (ALS) Defibrillators, Automated External Defibrillators (AEDs), Implantable Cardioverter Defibrillators (ICD), Wearable Defibrillators market. Further the Implantable Cardioverter Defibrillators (ICD) segment is sub segmented into Transvenous Implantable Cardioverter Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs) market. Based on the end use avenue, the market is bifurcated into Hospitals, Pre-hospitals, Public Access Markets, Alternate Care Markets, Home Healthcare market. The countries included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria and Rest of LAMEA. The report provides a comprehensive analysis of the key players operating in the world defibrillators market, such as Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.
Full report:https://www.kbvresearch.com/lamea-defibrillators-market/
The market is segmented based on product type, end use and country.
Related Reports:
Unique Offerings 
